Certmedica International GmbH is specialized in pharmacy-exclusive medical devices and operates its business from Aschaffenburg. In the German pharmacy market, Formoline L112 and Formoline L112 Extra hold leading positions with approximately 37% market share; in Austria their share is about 33%. The company is 100% owned by RD Invest GmbH and has a subsidiary, Biomedia Pharma GmbH (short: Biomedica), subject to a profit transfer and control agreement. For quality assurance, Certmedica maintains a certified quality management system according to DIN EN ISO 13485 and additionally follows GMP guidelines in manufacturing.
Die Certmedica International GmbH entwickelt, produziert und vertreibt Medizinprodukte, Nahrungsergänzungsmittel und Kosmetika und handelt als pharmazeutischer Unternehmer und Großhändler mit Arzneimitteln
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Aschaffenburg Local Court, HRB 9414 (as of 28 September 2026)
Source: German Commercial Register (Handelsregister) Aschaffenburg Local Court, HRB 9414 (as of 28 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Aschaffenburg Local Court, HRB 9414 (as of 28 September 2026)
MARVECS GmbH Marketing- Vertrieb-Consulting-Service
Ulm · Großhandel mit pharmazeutischen Erzeugnissen
Sebia Labordiagnostische Systeme GmbH
Mainz · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
EMA Indutec GmbH
Meckesheim · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
Sign in to view detailed salary and cost trends.
